APA aipamena

Hecht, J. R., Mitchell, E. P., Yoshino, T., Welslau, M., Lin, X., Chow Maneval, E., . . . Kretzschmar, A. (2015). 5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: A randomized Phase IIb study. Cancer Manag Res.

Chicago Style aipamena

Hecht, J Randolph, Edith P. Mitchell, Takayuki Yoshino, Manfred Welslau, Xun Lin, Edna Chow Maneval, Jolanda Paolini, Maria Jose Lechuga, and Albrecht Kretzschmar. "5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Plus Sunitinib or Bevacizumab As First-line Treatment for Metastatic Colorectal Cancer: A Randomized Phase IIb Study." Cancer Manag Res 2015.

MLA aipamena

Hecht, J Randolph, et al. "5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Plus Sunitinib or Bevacizumab As First-line Treatment for Metastatic Colorectal Cancer: A Randomized Phase IIb Study." Cancer Manag Res 2015.